Implanted Standby Defibrillators
To The Editor:
I am concerned about the implications of the Editorial by Drs. Lown and Axelrod which appeared in the October 1972 issue of Circulation. Although the authors rightfully point out the numerous technical problems still to be overcome in the development of such defibrillators, their conclusions in the last three paragraphs indicate a heavy bias in favor of "practical research." Although Dr. Lown has been eminently successful with this approach, I believe he is unjustified in using this yardstick to evaluate the research activities of others. The authors take Drs. Mirowski conditions of extreme ischemia.4 5 As far as endomyocardial effects of catheter electroshock are concerned, the lesions, when present, are small, localized, and of little significance in view of the otherwise fatal outcome of the arrhythmia. Fortunately, Dr. Lown's findings of myocardial damage due to transthoracic DC electroshock6 have not led to the abandonment of this technic by the medical profession.
In contrast to Drs. Lown and Axelrod, we do not foresee difficulties in identifying populations at particularly high risk of dying from ventricular fibrillation. The implantation of the transvenous automatic defibrillator in these patients may not necessarily be more "burdening" (using the authors' expression) than drug therapy. In fact, at this time we are aware of no effective long-term antiarrhythmic regimen capable of reducing the present prohibitive toll of sudden coronary deaths.
The authors' overcautious and negative attitude to the approach under investigation seems certainly premature at this experimental prototype stage. Would it not be more appropriate to postpone disqualification of this new way of approaching a major cause of mortality, however imperfect it may seem to be, until it faces the test of clinical trials?
Regrettably The clinical question still remains, for whom is such a device intended? If Mirowski and co-workers have found a method for precisely identifying the patient susceptible to sudden death, they remain remarkably modest in divulging such valuable knowledge. The undue enthusiasm for their device is exposed by the dismaying concept that the surgical insertion of a power plant within the body may not be more "burdening" than swallowing of pills.
But, there is a broader issue not dealt with in the Editorial or in these letters which relates to medical priorities. No society, whatever its wealth, can adequately respond to all social needs. Indeed within our own society the brief honeymoon between bountiful government and scientific investigative undertakings is coming to an end. It will be increasingly essential to define precisely the competitive position of health requirements to other legitimate societal goals. Within medicine itself support for investgative endeavor will need to be justified in relation not only to cost but to certain not problematic benefits. We continue to be unpersuaded that a complex, untestable, and costly electronic device provides a legitimate answer to the problem of sudden death justifying diversion of scarce social resources for its development.
In Possibly the discrepant findings mentioned above may be explained by the effect of potassium or some artifact of the experimental preparation. It would seem important to resolve these differing results in an attempt to explain the useful effects of procaine amide on an electrophysiologic basis.
